MTOR antibody (AA 2226-2488)
Quick Overview for MTOR antibody (AA 2226-2488) (ABIN7626898)
Target
See all MTOR (mTOR) AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 2226-2488
-
Purpose
- Serine/threonine-protein kinase mTOR (mTOR) Polyclonal Antibody
-
Sequence
- Ala2226~Val2488
-
Characteristics
- The Serine/threonine-protein kinase mTOR (mTOR) Polyclonal Antibody (Species: Rat) has been validated for the following applications: WB, IHC, ICC, IP.
-
Purification
- Antigen-specific affinity chromatography followed by Protein A affinity chromatography
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.5 mg/mL
-
Buffer
- 0.01M PBS, pH 7.4, containing 0.05 % Proclin-300, 50 % glycerol
-
Preservative
- ProClin
-
Precaution of Use
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- 4 °C,-20 °C
-
Storage Comment
- 2°C to 8°C for frequent use, -20°C for 12 months. Avoid repeated freeze/thaw cycles.
-
Expiry Date
- 12 months
-
-
- MTOR (mTOR) (Mechanistic Target of Rapamycin (serine/threonine Kinase) (mTOR))
-
Alternative Name
- mTOR
-
Gene ID
- 56718
-
UniProt
- P42346
-
Pathways
- PI3K-Akt Signaling, RTK Signaling, AMPK Signaling, Interferon-gamma Pathway, Fc-epsilon Receptor Signaling Pathway, EGFR Signaling Pathway, Neurotrophin Signaling Pathway, Regulation of Actin Filament Polymerization, Regulation of Muscle Cell Differentiation, Regulation of Cell Size, Skeletal Muscle Fiber Development, Regulation of Carbohydrate Metabolic Process, Autophagy, CXCR4-mediated Signaling Events, BCR Signaling, Warburg Effect
Target
-